Tango Therapeutics has reported an 82% objective response rate with [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

Racura Oncology has treated the first patient in its Harness-1 [...]

Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

On World Cancer Day (WCD), Affibody highlights its progress in [...]